Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

STUDIES ON MODIFICATION OF THE MORPHINE ABSTINENCE SYNDROME BY DRUGS

C. K. HIMMELSBACH and HOWARD L. ANDREWS
Journal of Pharmacology and Experimental Therapeutics January 1943, 77 (1) 17-23;
C. K. HIMMELSBACH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HOWARD L. ANDREWS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The morphine abstinence syndrome of moderate intensity is sufficiently uniform from the 24th to the 40th hour to permit reasonably accurate prediction of its course from the 30th to 40th hour from data obtained during the preceding 6 hours. A method is described for measuring the effect of drugs administered at the 30th hour of abstinence as percentage deviations from the expected course of the abstinence syndrome. Results by this method confirm the ineffectiveness of thiamine and indicate that prostigmin, pentobarbital, and atropine in the doses given do not ameliorate abstinence syndrome intensity appreciably. Codeine in 26 mgm. dosage also was ineffective. Pyridoxine caused a slight but presumably non-significant reduction. Diethyl-aminomethyl-3-phenanthryl carbinol caused a prolonged and probably significant reduction. Significant reductions were caused by 52 and 104 mgm. codeine; 5, 10, and 20 mgm. morphine; 100 and 200 mgm. Demerol; and by 80 mgm. morphine sulfuric ether. The extent of ameliorative effect increased somewhat with dosage. Prostigmin did not potentiate this effect of morphine. The effect of 20 mgm. morphine intravenously was greater and more sustained than an equal amount given subcutaneously. While these results confirm the cross-effectiveness of drugs structurally or pharmacologically similar to morphine, the dose relationships were not the same as found by substitution. Although this method probably will not be useful for studying the duration of action of drugs, the technique offers a quick method for detecting probable addiction liability of drugs.

Footnotes

    • Received September 7, 1942.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 77, Issue 1
1 Jan 1943
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
STUDIES ON MODIFICATION OF THE MORPHINE ABSTINENCE SYNDROME BY DRUGS
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

STUDIES ON MODIFICATION OF THE MORPHINE ABSTINENCE SYNDROME BY DRUGS

C. K. HIMMELSBACH and HOWARD L. ANDREWS
Journal of Pharmacology and Experimental Therapeutics January 1, 1943, 77 (1) 17-23;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

STUDIES ON MODIFICATION OF THE MORPHINE ABSTINENCE SYNDROME BY DRUGS

C. K. HIMMELSBACH and HOWARD L. ANDREWS
Journal of Pharmacology and Experimental Therapeutics January 1, 1943, 77 (1) 17-23;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Effects of Antidepressants and Benzodiazepine-Type Anxiolytic Agents on Hepatic Porphyrin Accumulation in Primary Cultures of Chick Embryo Liver Cells
  • Evidence That Melanocortin 4 Receptor Mediates Hemorrhagic Shock Reversal Caused by Melanocortin Peptides
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics